Succinic Acid

Succinic Acid

SCHEMBL508331

CC(C)(C)CC(=O)c1ccc(CNc2c(Cl)ccc3c2CCNCC3)c(F)c1.O=C(O)CCC(=O)O

nearest known ligand 0.33

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ADRB1CDK4CDK6CHRM2CHRM3DPP4DRD2DRD3DRD4EGFRHRH1HTR1BHTR1DHTR1FHTR2AHTR2CHTR4SLC6A2SLC6A4

The experimentally established mechanism targets of Succinic Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
HTR2C known ✓ P28335 3/20 0.33
HTR2A known ✓ P28223 2/20 0.33
SLC6A2 known ✓ P23975 1/20 0.30
SLC6A4 known ✓ P31645 1/20 0.30
EPHX2 P34913 1/20 0.33
NR1H4 Q96RI1 1/20 0.33
HTR2B P41595 3/20 0.33
ACHE P22303 1/20 0.32
WDR5 P61964 4/20 0.31
HDAC1 Q13547 1/20 0.30
HDAC6 Q9UBN7 1/20 0.30
CYP2D6 P10635 1/20 0.30
SLC6A3 Q01959 1/20 0.30
MCHR1 Q99705 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL508090 0.96 HTR2C (0.36) EPHX2NR1H4HTR2CHTR2BHTR2A
Succinic Acid SCHEMBL508495 0.92 EPHX2 (0.35) EPHX2NR1H4HTR2CHTR2BHTR2A
SCHEMBL507850 0.88 HTR2C (0.36) EPHX2NR1H4HTR2CHTR2BHTR2A
Succinic Acid SCHEMBL10476106 0.87 HTR2C (0.37) HTR2CHTR2BHTR2AWDR5
Succinic Acid SCHEMBL508270 0.86 HTR2A (0.35) EPHX2NR1H4HTR2CHTR2BHTR2A
Succinic Acid SCHEMBL508282 0.85 PTGER2 (0.38) HTR2CHTR2BHTR2A
Succinic Acid SCHEMBL507622 0.83 NR1H4 (0.35) EPHX2NR1H4HTR2CHTR2BHTR2A
SCHEMBL508084 0.81 HTR2A (0.39) HTR2CHTR2BHTR2AACHEHDAC1
Succinic Acid SCHEMBL507176 0.80 FFAR1 (0.36) NR1H4HTR2CHTR2BHTR2AACHE
Succinic Acid SCHEMBL10476315 0.80 HSD11B1 (0.40) HTR2CHTR2BHTR2ACYP2D6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1720836-B1 6-SUBSTITUTED 2,3,4,5-TETRAHYDRO-1H-BENZO [D]AZEPINES AS 5-HT2C RECEPTOR AGONISTS LILLY CO ELI (US) 2014-04-16 EP disclosed
US-8580780-B2 6 substituted 2, 3,4,5 tetrahydro-1H-benzo[d]azepines as 5-HT2C receptor agonist ELI LILLY AND COMPANY (US) 2013-11-12 US disclosed
EP-2479168-A1 6-Substituted 2,3,4,5-Tetrahydro-1H-Benzo [d]Azepines as 5-HT2C Receptor Agonists ELI LILLY AND COMPANY (US) 2012-07-25 EP disclosed
US-20120028961-A1 6 Substituted 2, 3,4,5 Tetrahydro-1H-Benzo[d]Azepines as 5-HT2c Receptor Agonist ELI LILLY AND COMPANY (US) 2012-02-02 US disclosed
US-8022062-B2 6-substituted 2,3,4,5-tetrahydro-1H-benzo[d]azepines as 5-HT2C receptor agonists ELI LILLY AND COMPANY (US) 2011-09-20 US disclosed
US-20090099155-A1 6-SUBSTITUTED 2,3,4,5-TETRAHYDRO-1H-BENZO[D]AZEPINES AS 5-HT2C RECEPTOR AGONISTS ARRAY BIOPHARMA, INC. 2009-04-16 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090099155-A1 6-SUBSTITUTED 2,3,4,5-TETRAHYDRO-1H-BENZO[D]AZEPINES AS 5-HT2C RECEPTOR AGONISTS HTR2C, HTR5A, HTR4 HTR2C 1/4885HTR2A 4/4885SLC6A2 259/4885
US-20120028961-A1 6 Substituted 2, 3,4,5 Tetrahydro-1H-Benzo[d]Azepines as 5-HT2c Receptor Agonist HTR2C, HTR4, HTR1A HTR2C 1/4885HTR2A 4/4885SLC6A2 223/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.